Scientific leader with 10+ years of experience in leading pharmaceutical development of small molecule formulations (tablets, capsules, long-acting formulations, implants, liposomes, lipid nanopartickes), biologics (antibody, ADC, proteins, peptides), RNA and oligonucleotides (mRNA, siRNA)* Expert in formulation and analytical development of biologics & small molecules* SME in long-acting formulations; Delivery systems such as LNPs, liposomes, lipid emulsions, polyplexes, microparticles, conjugates, implants, micelles, drug extrusions, etc.* Experienced in targeted therapies and ligands and peptides/sugars in RGD, NGR, LyP-1, Neuropilin, PSMA, transferrin, galactose, mannose targeting.* Device experience including ophthalmic devices, preservative-free bottles, implants, syringes, IV bags and sustained / controlled release platforms.* Analytical Method development, validation, qualification, QC/QA with SEC, UPLC/IEX, AKTA, UV, gel etc.* Biophysical expertise in DLS, MFI, soloVPE, FTIR, NMR, DSC, HIAC, TEM, etc.* Expert in dissolution testing, USP App I, II, IV; Content and uniformity testing; hardness / friability and other compendial methods* Manufacturing drug products (small molecule & Biologics) to support GLP tox and phase trials; Container closure studies, syringes, IV bags and its testings incl. bio/incompatibility testings etc. * Authored IND submissions, various CMC Modules 2 &3 and technical/clinical docs/dossiers. * Supervised/mentored 25+ PhD level scientists; Liased with several internal/external stakeholders, CRO/CDMOs and business leaders. * Provided critical support for R&D, tech transfer to GMP and enabled successful commercialization of various marketed products* Contributed to the incubation of 3-4 start-ups, acquired by major pharma* Life cycle management and support/risk mitigation of launched products